Even without hemodynamic compromise, certain patterns of bleeding require prompt same-day evaluation
The Precision Peptide Genetic Test analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline GLP-1 biology, upstream context that a subscription providing medication and follow-up does not capture on its own
In a clinical trial of patients with type 2 diabetes, weekly tirzepatide at 5, 10, or 15 mg for 40 weeks resulted in an 8.512.4% weight loss, compared to 6.7% with semaglutide at 1 mg/week [29]
Unlike the combinatorial therapy of G-protein-coupled receptor-based peptide dual agonists, such as GLP-1/glucagon, these peptidyl nuclear hormone conjugates require additional consideration for differential pharmacodynamics where time action for clearance of each activity is inherently dissimilar
For Canadians dealing with post-weight-loss skin laxity, injectable GHK-Cu offers a non-surgical option backed by over 40 years of scientific research and a strong safety profile
By Sujith Ramachandran and Liang-Yuan (Claire) Lin If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight loss journey on GLP-1 medications in a commercial